Rein Therapeutics Inc.
RNTX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $30 | $34 | $0 | $0 |
| - Cash | $4 | $6 | $7 | $13 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $26 | $28 | -$7 | -$13 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$6 | -$7 | -$6 | -$43 |
| % Margin | – | – | – | – |
| Net Income | -$6 | -$7 | -$6 | -$41 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.21 | -0.28 | -2,510.05 | -1.89 |
| % Growth | 25% | 100% | -132,706.9% | – |
| Operating Cash Flow | -$4 | -$6 | -$6 | -$5 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$4 | -$6 | -$6 | -$5 |